Skip to main content
رجوع
BIOA logo

BioAge Labs, Inc.

جودة البيانات: 100%
BIOA
NASDAQ Healthcare Biotechnology
KWD 16.11
▼ KWD 2.52 (-13.53%)
القيمة السوقية: 577.62M
نطاق اليوم
KWD 15.68 KWD 18.71
نطاق 52 أسبوعًا
KWD 2.88 KWD 24.00
حجم التداول
853,969
متوسط 50 يوم / 200 يوم
KWD 20.04 / KWD 10.02
الإغلاق السابق
KWD 18.63

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -7.2 0.4
P/B 2.1 2.9
ROE % -27.1 3.7
Net Margin % -896.1 3.9
Rev Growth 5Y % 10.0
D/E 0.0 0.2

السعر المستهدف للمحللين

Hold
KWD 42.500 +163.8%
Low: KWD 23.000 High: KWD 62.000
ربحية السهم المستقبلية
-KWD 2.764
الإيرادات المقدّرة
71 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 -KWD 3.593
-KWD 3.593 – -KWD 3.593
1.5 M 1
FY2028 -KWD 3.070
-KWD 3.516 – -KWD 2.586
1 M 3
FY2027 -KWD 2.729
-KWD 3.811 – -KWD 0.241
20 M 5

النقاط الرئيسية

Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -82.35M
PEG of 0.09 suggests growth is underpriced
Capital efficient — spends only 7.99% of revenue on capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-27.09%
ROIC-25.07%
Net Margin-896.11%
Op. Margin-1031.46%

الأمان

Debt / Equity
0.02
Current Ratio14.24
Interest Coverage133.11

التقييم

P/E Ratio
-7.17
P/B Ratio2.12
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 9.00M Net Income (TTM) -80.61M
ROE -27.09% ROA -27.33%
Gross Margin 0.00% Operating Margin -1031.46%
Net Margin -896.11% Free Cash Flow (TTM) -82.35M
ROIC -25.07% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.02 Current Ratio 14.24
Interest Coverage 133.11 Dividend Yield 0.00%
Valuation
P/E Ratio -7.17 P/B Ratio 2.12
P/S Ratio 64.22 PEG Ratio 0.09
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 577.62M Enterprise Value 394.30M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 9.00M 0.0 0.0 0.0
Net Income -80.61M -71.11M -63.85M -39.72M
EPS (Diluted) -2.24 -6.63 -8.55 -5.32
Gross Profit 0.0 0.0 0.0 0.0
Operating Income -92.78M -78.19M -48.40M -39.97M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 294.89M 358.23M 25.92M 28.43M
Total Liabilities 22.84M 35.11M 199.32M 140.99M
Shareholders' Equity 272.05M 323.13M -173.40M -112.56M
Total Debt 5.56M 8.70M 53.25M 2.47M
Cash & Equivalents 188.89M 354.35M 21.64M 27.64M
Current Assets 286.79M 357.10M 25.31M 28.03M
Current Liabilities 20.14M 27.78M 58.17M 5.86M